Literature DB >> 16085781

Population-based study of medical comorbidity in early dementia and "cognitive impairment, no dementia (CIND)": association with functional and cognitive impairment: The Cache County Study.

Constantine G Lyketsos1, Leslie Toone, JoAnn Tschanz, Peter V Rabins, Martin Steinberg, Chiadi U Onyike, Christopher Corcoran, Maria Norton, Peter Zandi, John C S Breitner, Kathleen Welsh-Bohmer, James Anthony, Truls Østbye, Erin Bigler, Carl Pieper, James Burke, Brenda Plassman, Robert C Green, David C Steffens, Liz Klein, Carol Leslie, Jeannette J Townsend, Bonita W Wyse, Ronald Munger, Michael Williams.   

Abstract

OBJECTIVE: Authors investigated medical comorbidity in persons with dementia and "Cognitive Impairment, No Dementia" (CIND).
METHODS: The Cache County Study is an ongoing population-based study of the epidemiology of dementia, the risk factors for conversion from CIND to dementia, and the progression of dementia. As part of the study's first incidence wave, persons with dementia (N=149), CIND (N=225), or without cognitive impairment (N=321) were identified and studied. Participants received comprehensive clinical evaluations and were rated on the General Medical Health Rating (GMHR), a global measure of seriousness of medical comorbidity. Participants and informants also completed the Mini-Mental State Exam and provided self-report information about comorbid medical conditions and functioning in activities of daily living.
RESULTS: There were few differences in number or type of comorbid medical conditions between persons with CIND and dementia, but persons with dementia were prescribed more medications. Stroke was more common in dementia participants, but other illnesses common in old age were not significantly different across cognitive groups. Medical comorbidity was more serious in both dementia and CIND, such that both groups were less likely to have "little to no" comorbidity. Seriousness of medical comorbidity was significantly associated with worse day-to-day functioning and cognition.
CONCLUSIONS: Persons with CIND and dementia have more serious medical comorbidity than comparable persons without cognitive impairment. This comorbidity may play a role in the progression of CIND and dementia. Future studies should investigate the role of medical comorbidity and its treatment on dementia onset or progression, as well as the mechanisms mediating its neuropathologic effects.

Entities:  

Mesh:

Year:  2005        PMID: 16085781     DOI: 10.1176/appi.ajgp.13.8.656

Source DB:  PubMed          Journal:  Am J Geriatr Psychiatry        ISSN: 1064-7481            Impact factor:   4.105


  37 in total

1.  Effects of general medical health on Alzheimer's progression: the Cache County Dementia Progression Study.

Authors:  Jeannie-Marie S Leoutsakos; Dingfen Han; Michelle M Mielke; Sarah N Forrester; JoAnn T Tschanz; Chris D Corcoran; Robert C Green; Maria C Norton; Kathleen A Welsh-Bohmer; Constantine G Lyketsos
Journal:  Int Psychogeriatr       Date:  2012-06-12       Impact factor: 3.878

2.  Multimorbidity and Risk of Mild Cognitive Impairment.

Authors:  Maria Vassilaki; Jeremiah A Aakre; Ruth H Cha; Walter K Kremers; Jennifer L St Sauver; Michelle M Mielke; Yonas E Geda; Mary M Machulda; David S Knopman; Ronald C Petersen; Rosebud O Roberts
Journal:  J Am Geriatr Soc       Date:  2015-08-27       Impact factor: 5.562

3.  Commentary on Apathy as a Model for Investigating Behavioral and Psychological Symptoms in Dementia.

Authors:  Andrea Gilmore-Bykovskyi
Journal:  J Am Geriatr Soc       Date:  2018-04       Impact factor: 5.562

Review 4.  Dementia and co-occurring chronic conditions: a systematic literature review to identify what is known and where are the gaps in the evidence?

Authors:  Mark B Snowden; Lesley E Steinman; Lucinda L Bryant; Monique M Cherrier; Kurt J Greenlund; Katherine H Leith; Cari Levy; Rebecca G Logsdon; Catherine Copeland; Mia Vogel; Lynda A Anderson; David C Atkins; Janice F Bell; Annette L Fitzpatrick
Journal:  Int J Geriatr Psychiatry       Date:  2017-02-01       Impact factor: 3.485

5.  Cognitive problems in patients on androgen deprivation therapy: a qualitative pilot study.

Authors:  Lisa M Wu; Michael A Diefenbach; Wayne A Gordon; Joshua B Cantor; Monique M Cherrier
Journal:  Urol Oncol       Date:  2012-09-10       Impact factor: 3.498

6.  When help becomes a hindrance: mental health referral systems as barriers to care for primary care physicians treating patients with Alzheimer's disease.

Authors:  Carol E Franz; Judith C Barker; Kathleen Kim; Yvette Flores; Cecily Jenkins; Richard L Kravitz; Ladson Hinton
Journal:  Am J Geriatr Psychiatry       Date:  2010-07       Impact factor: 4.105

7.  Use of FDA approved medications for Alzheimer's disease in mild dementia is associated with reduced informal costs of care.

Authors:  Stephanie Behrens; Gail B Rattinger; Sarah Schwartz; Joshua Matyi; Chelsea Sanders; M Scott DeBerard; Constantine G Lyketsos; JoAnn T Tschanz
Journal:  Int Psychogeriatr       Date:  2018-03-21       Impact factor: 3.878

Review 8.  Risk factors for the progression of mild cognitive impairment to dementia.

Authors:  Noll L Campbell; Fred Unverzagt; Michael A LaMantia; Babar A Khan; Malaz A Boustani
Journal:  Clin Geriatr Med       Date:  2013-11       Impact factor: 3.076

9.  The impact of vascular comorbidities on qualitative error analysis of executive impairment in Alzheimer's disease.

Authors:  Melissa Lamar; David J Libon; Angela V Ashley; James J Lah; Allan I Levey; Felicia C Goldstein
Journal:  J Int Neuropsychol Soc       Date:  2009-10-19       Impact factor: 2.892

10.  Vascular factors and risk for neuropsychiatric symptoms in Alzheimer's disease: the Cache County Study.

Authors:  Katherine A Treiber; Constantine G Lyketsos; Chris Corcoran; Martin Steinberg; Maria Norton; Robert C Green; Peter Rabins; David M Stein; Kathleen A Welsh-Bohmer; John C S Breitner; JoAnn T Tschanz
Journal:  Int Psychogeriatr       Date:  2008-02-21       Impact factor: 3.878

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.